MINNEAPOLIS, April 20, 2017 /PRNewswire/ -- Cogentix
Medical, Inc. (NASDAQ: CGNT), a global medical device company
focused on providing the Urology, Uro/Gyn and Gynecology markets
with innovative and proprietary products, today reported that Ash
Keswani has joined the Company as Senior Vice President, Marketing
& Business Development. In this newly created position, Mr.
Keswani will report directly to Darin
Hammers, President and CEO.
"Our organization is delighted that Ash has joined the Cogentix
team," said Mr. Hammers. "He brings significant medical device
experience and proven marketing leadership on a global level. In
his new role, Ash will build on our momentum by developing and
driving additional strategies that amplify the value proposition of
our PrimeSight and Urgent PC Urology product lines. He will also
have a significant impact in assessing and advancing business
development opportunities, an area where he brings extensive
Urology expertise and one that is key to our company building
shareholder returns."
Mr. Keswani's experience spans more than 20 years in the medical
industry. His work has ranged from disposables to implantable
devices in the fields of Urology, Gynecology and Cardiac
Surgery. Most recently, Mr. Keswani served as President of
Urologix, a privately-held medical device company. He has also held
senior-level marketing positions at American Medical Systems,
Medtronic, Coloplast and Nonin Medical. Mr. Keswani received
his B.A. from Gustavus Adolphus College
in St. Peter, MN.
About Cogentix Medical
Cogentix Medical, Inc.,
headquartered in Minnetonka,
Minnesota, with additional operations in New York, Massachusetts, The
Netherlands and the United
Kingdom, is a global medical device company. We
design, develop, manufacture and market products for flexible
endoscopy with our unique PrimeSight™ product lines featuring a
streamlined visualization system and proprietary sterile disposable
microbial barrier providing users with efficient and cost effective
endoscope turnover while enhancing patient safety. We also
commercialize the Urgent® PC Neuromodulation System, an FDA-cleared
device that delivers percutaneous tibial nerve stimulation (PTNS)
for the office-based treatment of overactive bladder (OAB). OAB is
a chronic condition that affects approximately 42 million U.S.
adults. The symptoms include urinary urgency, frequency and urge
incontinence. We also offer Macroplastique®, an injectable
urethral bulking agent for the treatment of adult female stress
urinary incontinence primarily due to intrinsic sphincter
deficiency. For more information on Cogentix Medical and our
products, please visit us at www.cogentixmedical.com. 'CGNT-G'
For Further Information:
Cogentix Medical, Inc.
Brett Reynolds, SVP and CFO
952-426-6152
EVC Group
Brian Moore/Doug Sherk
310-579-6199/415-652-9100
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ash-keswani-joins-cogentix-medical-as-svp-of-marketing-and-business-development-300442392.html
SOURCE Cogentix Medical, Inc.